Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationKidney TransplantationTransplantation ConditioningGraft SurvivalGraft RejectionTreatment OutcomeRecurrenceImmunosuppressive AgentsHematopoietic Stem Cell MobilizationRetrospective StudiesHodgkin DiseaseMultiple MyelomaTissue DonorsTransplantsHistocompatibility TestingGraft vs Host DiseaseSurvival AnalysisTime FactorsHematologic NeoplasmsPostoperative ComplicationsHeart TransplantationTransplantationBlood Transfusion, AutologousLung TransplantationCombined Modality TherapyAcute DiseaseLiver TransplantationTissue and Organ ProcurementCyclosporineTacrolimusImmunosuppressionLiving DonorsWaiting ListsPost and Core TechniqueCytomegalovirus InfectionsFetal Tissue TransplantationMycophenolic AcidStem Cell TransplantationTransplantation ImmunologyFollow-Up StudiesCadaverImmunocompromised HostKidney Failure, ChronicLiver FailureRisk FactorsSurvival RateHeart-Lung TransplantationBrain Tissue TransplantationHLA AntigensWhole-Body IrradiationProspective StudiesTransplantation, HeterotopicHistocompatibilityT-LymphocytesMelphalanPeripheral Blood Stem Cell TransplantationBronchiolitis ObliteransOpportunistic InfectionsCytomegalovirusTransplantation ToleranceAntilymphocyte SerumBiopsyCyclophosphamideTransplantation, IsogeneicBK VirusIsoantibodiesCell TransplantationLymphoproliferative DisordersLymphoma, Non-HodgkinKidneyPrognosisGanciclovirAntineoplastic Combined Chemotherapy ProtocolsBone Marrow PurgingIslets of Langerhans TransplantationPolyomavirus InfectionsIncidenceKidney DiseasesLiver DiseasesLymphocyte Culture Test, MixedPostoperative PeriodCreatinineLeukemiaEnd Stage Liver DiseaseMycosesDisease-Free SurvivalFatal OutcomeTissue TransplantationBusulfanSalvage TherapyLymphocyte ActivationCarmustineInfectionCytotoxicity, ImmunologicCohort StudiesAntiviral AgentsCells, Cultured